Provided by Tiger Fintech (Singapore) Pte. Ltd.

POINT BIOPHARMA GLOBAL INC

12.50
+0.0000
Volume:- -
Turnover:41.13M
Market Cap:1.33B
PE:13.92
High:12.50
Open:12.50
Low:12.50
Close:12.50
Loading ...
Dec 28, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Dec 27, 2023

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Dec 27, 2023

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Dec 27, 2023

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Dec 27, 2023

Delisting

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Dec 27, 2023

Major Issues Report

Form 8-K - Current report
Dec 20, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 13, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Oct 04, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Oct 03, 2023

Major Issues Report

Form 8-K - Current report
Aug 14, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 14, 2023

Major Issues Report

Form 8-K - Current report
Aug 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Jun 14, 2023

Major Issues Report

Form 8-K - Current report